Bulletin
Investor Alert

New York Markets Close in:

Market Pulse Archives

July 19, 2021, 8:18 a.m. EDT

CDC vaccine committee to discuss COVID-19 booster doses for immunocompromised people this week

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Johnson & Johnson (JNJ)

or Cancel Already have a watchlist? Log In

By Jaimy Lee

JNJ

The Centers for Disease Control and Prevention's influential vaccine advisory committee plans to meet Thursday to discuss the new safety warning for Johnson & Johnson's /zigman2/quotes/201724570/composite JNJ +0.53% COVID-19 vaccine and whether immunocompromised people will need a booster dose of a COVID-19 shot. The CDC's Advisory Committee on Immunization Practices has met several times during the pandemic to discuss COVID-19 vaccines. The meeting will be webcast.

/zigman2/quotes/201724570/composite
US : U.S.: NYSE
$ 168.52
+0.88 +0.53%
Volume: 4.16M
Jan. 26, 2022 1:41p
P/E Ratio
21.57
Dividend Yield
2.52%
Market Cap
$441.30 billion
Rev. per Employee
$697,212
loading...

Get news alerts on Johnson & Johnson — or create your own.
This Story has 0 Comments
Be the first to comment
More News In
Industries

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.